Effect of reperfusion on electrocardiographic and enzymatic infarct size: Results of a randomized multicenter study of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) versus intracoronary streptokinase in acute myocardial infarction
- 1 October 1988
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 116 (4) , 903-914
- https://doi.org/10.1016/0002-8703(88)90140-8
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator in patients with acute myocardial infarction.Circulation, 1986
- Coronary thrombolysis during acute myocardial infarction by intravenous BRL 26921, a new anisoylated plasminogen-streptokinase activator complexThe American Journal of Cardiology, 1986
- Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.Circulation, 1986
- Intravenous urokinase in acute myocardial infarctionThe American Journal of Cardiology, 1985
- Percutaneous transluminal coronary angioplasty: Application for acute myocardial infarctionThe American Journal of Cardiology, 1984
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Intravenous short-term infusion of streptokinase in acute myocardial infarction.Circulation, 1983
- Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris.Circulation, 1981
- Intracoronary thrombolysis in evolving myocardial infarctionAmerican Heart Journal, 1981
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980